Serge Verreault
Chief Executive Officer bei CRESCITA THERAPEUTICS INC.
Vermögen: 218 817 $ am 29.02.2024
Profil
Serge Verreault is currently the President, Chief Executive Officer & Director at Crescita Therapeutics, Inc. He previously worked as the Executive Director-Business Development at Valeant Canada Ltd.
from 2012 to 2017.
Before that, he was the General Manager at Laboratoire Dr. Renaud, Inc. Mr. Verreault completed his undergraduate degree and MBA from Université Laval.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
28.12.2023 | 741 751 ( 3,71% ) | 218 817 $ | 29.02.2024 |
Aktive Positionen von Serge Verreault
Unternehmen | Position | Beginn |
---|---|---|
CRESCITA THERAPEUTICS INC. | Chief Executive Officer | 02.04.2018 |
Ehemalige bekannte Positionen von Serge Verreault
Unternehmen | Position | Ende |
---|---|---|
Valeant Canada Ltd.
Valeant Canada Ltd. Pharmaceuticals: MajorHealth Technology Valeant Canada Ltd. manufactures and distributes pharmaceutical products to both primary care and physicians in Canada. The firm focuses its efforts primarily in the areas of pain management, cardiovascular disease, neurology and dermatology. The company was founded in 1956 and is headquartered in Laval, Canada. | Corporate Officer/Principal | 01.04.2017 |
Laboratoire Dr. Renaud, Inc.
Laboratoire Dr. Renaud, Inc. Other Consumer ServicesConsumer Services Laboratoire Dr. Renaud, Inc. offers innovative skin care products. It offers skin care and environment solutions. The company was founded in 1947 by Louis Raymond Renaud. Driven by its passion and constant quest for innovation, its Research & Development team is totally dedicated to the advance study of the skin. The success of the company lies on years of research and close collaboration with University Scientists and Experts in dermopharmacology | Chief Executive Officer | - |
Ausbildung von Serge Verreault
Université Laval | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
CRESCITA THERAPEUTICS INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
Laboratoire Dr. Renaud, Inc.
Laboratoire Dr. Renaud, Inc. Other Consumer ServicesConsumer Services Laboratoire Dr. Renaud, Inc. offers innovative skin care products. It offers skin care and environment solutions. The company was founded in 1947 by Louis Raymond Renaud. Driven by its passion and constant quest for innovation, its Research & Development team is totally dedicated to the advance study of the skin. The success of the company lies on years of research and close collaboration with University Scientists and Experts in dermopharmacology | Consumer Services |
Valeant Canada Ltd.
Valeant Canada Ltd. Pharmaceuticals: MajorHealth Technology Valeant Canada Ltd. manufactures and distributes pharmaceutical products to both primary care and physicians in Canada. The firm focuses its efforts primarily in the areas of pain management, cardiovascular disease, neurology and dermatology. The company was founded in 1956 and is headquartered in Laval, Canada. | Health Technology |